Senna Lax
- Product NDC
- 69168-371
- 11-digit product format
- 691680371
- Labeler code
- 69168
- Product ID
- 69168-371_3d9f08e0-645d-4780-93aa-1982483e7b90
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Sennosides 8.6mg
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Allegiant Health
- Application
- M007
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start
- 2014-07-01
- Substance
- SENNOSIDES
- Active strength
- 8.6 mg/1
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Senna Lax
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| SENNOSIDES | 8.6 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 3FYP5M0IJX |
| Rxcui | 312935 |
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 69168-371-17 | Senna Lax | 300 in 1 BOTTLE | TABLET | 300 | | 5 |
| 69168-371-30 | Senna Lax | 30 in 1 BOTTLE | TABLET | 30 | | 5 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 69168-371 | SENNA LAX (SENNOSIDES 8.6MG) TABLET [ALLEGIANT HEALTH] | 5 | Current NDC, Legacy NDC, 2 package rows | 20231007_94a9c24a-07c3-4535-b810-b7abc9fc5ad5.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 69168-371-17 | 69168037117 | 300 TABLET in 1 BOTTLE (69168-371-17) | 300 tablet | 2022-05-18 | 0000-00-00 | No | No | Current |
| 69168-371-30 | 69168037130 | 30 TABLET in 1 BOTTLE (69168-371-30) | 30 tablet | 2014-07-01 | 2021-12-30 | No | No | Current |